High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia

AIDS Reader

Volumn 12, Issue 5, 2002, Pages 222-224

  McComsey, Grace A ^a   Lederman, Michael M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperlactatemia; Lactic acidosis; Mitochondrial toxicity

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DIDANOSINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; RIBOFLAVIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; THIAMINE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; MALE; SECONDARY PREVENTION;

ACIDOSIS, LACTIC; ADULT; AGED; FEMALE; HIV INFECTIONS; HUMANS; MALE; REVERSE TRANSCRIPTASE INHIBITORS; RIBOFLAVIN; THIAMINE;

EID: 0036092072     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Incidence and outcome of hyperlactatemia associated with clinical manifestations in HIV-infected adults receiving NRTI-containing regimens
2. Symptomatic hyperlactatemia: An emerging complication of antiretroviral therapy
3. Thiamine deficiency and Wernicke's encephalopathy in AIDS
4. Water-soluble vitamins: The vitamin B complex and ascorbic acid
5. Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis
6. Riboflavin and severe lactic acidosis
7. Riboflavin to treat nucleoside analogue-induced lactic acidosis
8. Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analogue antiretroviral therapy
9. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: Lactic acidosis, risk factors and therapeutic options
10. Emerging complications of antiretroviral therapy: Symptomatic hyperlactatemia